Reference Interval:
| Test Number
| Components
| Reference Interval
| | 0051618 | Rett Syndrome (MECP2), Deletion and Duplication
| By report
| | 0051378 | Rett Syndrome (MECP2), Full Gene Sequencing
| By report
|
|
| Interpretive Data: |
Background Information
Characteristics: Classic Rett syndrome is a progressive neurodevelopmental disorder characterized by normal development until 6-18 months of age followed by rapid developmental regression, deceleration of head growth, loss of speech and acquired motor skills, and seizures; purposeful use of the hands is replaced by repetitive stereotyped hand movements. MECP2-Related disorders include Rett-like syndrome, severe congenital encephalopathy, or mild to severe mental retardation.
Incidence: 1 in 10,000.
Inheritance: X-linked dominant; most cases are sporadic.
Cause: Methyl-CpG-Binding Protein 2 (MECP2) gene mutations.
Clinical Sensitivity: Up to 95%.
Methodology: bidirectional sequencing of the entire coding region and intron-exon boundaries; Multiplex Ligation-dependent Probe Amplification (MLPA) to detect large MECP2 deletions /duplications; oligonucleotide probes cover all MECP2 in the coding region.
Analytical Sensitivity: 99% for sequencing and 90% for MLPA.
Analytic Specificity: 99% for sequencing and 98% for MLPA.
Limitations: Breakpoints of large deletions/duplications cannot be determined; deep intronic mutations will not be detected; analytical sensitivity may be compromised by rare primer site mutations.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.
Refer to Statement C under Testing Information at http://www.aruplab.com.
|
| CPT Code(s): |
Rett sequencing: 83891 Isolation; 83898 x7 Amplification; 83904 x6 Sequencing; 83909 Capillary electrophoresis; 83912 Interpretation and report. RETT MLPA: 83896 Nucleic acid probe; 83914 Extension; 83898 Amplification; 83909 Capillary electrophoresis.
|
Cross References: |
MECP2 (Rett Syndrome (MECP2), Full Gene Analysis)
|
![[ image for: Patient History for Rett Syndrome (MECP2) or CDKL5-Related Disorders (CDKL5) Testing]](icon_30.jpg){kind=icon}